Skip to main content
. 2022 Apr 26;42(9):1067–1076. doi: 10.1093/asj/sjac106

Table 2.

Analysis to Find Baseline Characteristics That Are Predictive of a Patient Self-Reporting BII—Metals

Baseline characteristic BII vs non-BII
(Cohort A vs Cohort B)
BII vs mastopexy
(Cohort A vs Cohort C)
Reference
category
Odds ratio P value Odds ratio P value
Tobacco history Never
 Former 1.304 0.5634 2.529 0.0725
 Current >999 0.0864 >999 0.0734
Marijuana use Never
 Former 1.277 0.6479 3.486 0.0758
 Current >999 0.0156 1.163 0.8390
Medications
 Antibiotics (yes/no) No 2.538 0.1096 13.820 0.0138
 Aspirin/NSAID (yes/no) No 14.461 <0.0001 10.615 <0.0001
 Prescription pain medications (yes/no) No >999 0.0032 1.568 0.5076
 Other herbal/nonprescription medicines (yes/no) No 4.636 0.0060 1.325 0.5171
Any allergy (yes/no) No 1.405 0.4769 4.909 0.0005
Allergy: gluten (yes/no) No 7.977 0.0566 >999 0.0015
Allergy: wheat (yes/no) No 4.261 0.2023 >999 0.0177
Tattoos (yes/no) No 2.681 0.0172 1.043 0.2309

BII indicates those patients seeking explantation because they believe their implants are responsible for their symptoms. Cohort A: patients with self-reported BII requesting explantation; Cohort B: patients requesting implant exchange or explantation without self-reported BII; Cohort C: patients with mastopexy (without soft-tissue support or implants). The odds ratios and P values are from a logistic regression analysis with group as the dependent variable and the baseline characteristic as the explanatory variable. The P value is for a 2-sided test of the null hypothesis that the true odds ratio equals 1. BII, breast implant illness; NSAID, nonsteroidal anti-inflammatory drug.